Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.503. It has been cited 12 times, with 11 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0.118
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.
National Institutes of Health, National Cancer Institute
Grant: CA180819
National Institutes of Health, National Cancer Institute
Grant: CA180821
National Institutes of Health, National Cancer Institute
Grant: CA180828
National Institutes of Health, National Cancer Institute
Grant: CA180888
National Institutes of Health, National Cancer Institute
Grant: CA233320
National Institutes of Health, National Cancer Institute
Grant: CA233331
Bristol-Myers Squibb Company
Grant: N/A
FWCI
5.52
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals